These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18729011)

  • 21. In vivo target validation using gene invalidation, RNA interference and protein functional knockout models: it is the time to combine.
    Vidalin O; Muslmani M; Estienne C; Echchakir H; Abina AM
    Curr Opin Pharmacol; 2009 Oct; 9(5):669-76. PubMed ID: 19646923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulated genes of extrinsic type of atopic dermatitis: 34K microarray and interactomic analyses.
    Lü ZR; Park TH; Lee ES; Kim KJ; Park D; Kim BC; Cho SW; Bhak J; Park YD; Zou F; Yang JM
    J Dermatol Sci; 2009 Feb; 53(2):146-50. PubMed ID: 18824329
    [No Abstract]   [Full Text] [Related]  

  • 23. Systems biology in human health and disease.
    Lemberger T
    Mol Syst Biol; 2007; 3():136. PubMed ID: 17893698
    [No Abstract]   [Full Text] [Related]  

  • 24. The resolution of the genetics of gene expression.
    Montgomery SB; Dermitzakis ET
    Hum Mol Genet; 2009 Oct; 18(R2):R211-5. PubMed ID: 19808798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic biology: exploring and exploiting genetic modularity through the design of novel biological networks.
    Agapakis CM; Silver PA
    Mol Biosyst; 2009 Jul; 5(7):704-13. PubMed ID: 19562109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Network benchmarking: a happy marriage between systems and synthetic biology.
    Minty JJ; Varedi K SM; Nina Lin X
    Chem Biol; 2009 Mar; 16(3):239-41. PubMed ID: 19318204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Special issue of statistical genetics and genomics in clinical trials: guest editor's note.
    Wu R; Lin M
    J Biopharm Stat; 2010 Mar; 20(2):191-2. PubMed ID: 20309753
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields.
    Sawyer TK
    Chem Biol Drug Des; 2006 Mar; 67(3):196-200. PubMed ID: 16611212
    [No Abstract]   [Full Text] [Related]  

  • 29. Identifying disease-causal genes using Semantic Web-based representation of integrated genomic and phenomic knowledge.
    Gudivada RC; Qu XA; Chen J; Jegga AG; Neumann EK; Aronow BJ
    J Biomed Inform; 2008 Oct; 41(5):717-29. PubMed ID: 18755295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative genomics--a basic and essential tool for the development of molecular medicine.
    Ostrowski J
    Acta Pol Pharm; 2008; 65(6):621-4. PubMed ID: 19172842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FANTOM studies networks in cells.
    Ledford H
    Nature; 2009 Apr; 458(7241):955. PubMed ID: 19396108
    [No Abstract]   [Full Text] [Related]  

  • 32. Rediscovering the role of natural products in drug discovery.
    Desai MC; Chackalamannil S
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):436-7. PubMed ID: 18600560
    [No Abstract]   [Full Text] [Related]  

  • 33. Modeling of gene regulatory network dynamics using threshold logic.
    Gowda T; Vrudhula S; Kim S
    Ann N Y Acad Sci; 2009 Mar; 1158():71-81. PubMed ID: 19348633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of genomics in clinical trial design.
    Simon R
    Clin Cancer Res; 2008 Oct; 14(19):5984-93. PubMed ID: 18829477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systems biology strikes gold.
    Camacho DM; Collins JJ
    Cell; 2009 Apr; 137(1):24-6. PubMed ID: 19345182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omics meets hypothesis-driven research. Partnership for innovative discoveries in vascular biology and angiogenesis.
    Rüegg C; Tissot JD; Farmer P; Mariotti A
    Thromb Haemost; 2008 Nov; 100(5):738-46. PubMed ID: 18989513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enabling a systems biology approach to immunology: focus on innate immunity.
    Gardy JL; Lynn DJ; Brinkman FS; Hancock RE
    Trends Immunol; 2009 Jun; 30(6):249-62. PubMed ID: 19428301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental advances in the characterization of metazoan gene regulatory networks.
    Deplancke B
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):12-27. PubMed ID: 19324929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein annotation at genomic scale: the current status.
    Frishman D
    Chem Rev; 2007 Aug; 107(8):3448-66. PubMed ID: 17658902
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.